Global Plasma Fractionation Market by Product Application End User: Global Opportunity Analysis and Industry Forecast, 2018-2028

Executive Summary

According to the report titled, 'Plasma fractionation Market by Product, Application, and Provider: Global Opportunity Analysis and Industry Forecast, 2018-2028', the global plasma fractionation market size was valued at $16.82 billion in 2018, and is expected to reach $30.53 billion by 2028, registering a CAGR of 6.1% from 2018 to 2028.

Plasma fractionation is a separation technique, which is employed for obtaining plasma derivatives. There are different types of plasma derivatives available in the market such as albumin, immunoglobulins, and others. These products contain concentrated fractions of plasma protein, which is obtained by fractionation of plasma collected from a large number of donors. Furthermore, plasma derivatives are employed in different medical aspects such as hematology, neurology, critical care, and others. For instance, immunoglobulins are used in neurology to help patients suffering from multiple sclerosis, neuropathic pain, and others. Furthermore, these products are extensively used in research laboratories and hospitals owing to surge in awareness related to their use in various medical fields.

The factors that boost the growth of the plasma fractionation market include surge in geriatric population across the globe which is predisposed to various rare diseases which require the use of plasma derivatives. Moreover, rise in use of immunoglobulins and alpha-1-antitrypsin in areas of medicine worldwide also fuel the growth of the plasma fractionation market. Furthermore, surge in plasma collection centers worldwide is another major factor that contributes to the growth of this market. In addition, favorable governmental support to spread awareness related to the use of plasma derived products also fuels the growth of the plasma fractionation market.

However, high cost of plasma derived products restricts the growth of the market. Conversely, growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period

The global plasma fractionation market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is divided into albumin, immunoglobulins, and coagulation factor VIII. Moreover, immunoglobulins are further divided into subcutaneous immunoglobulin (SCIG) and coagulation factor VIII. By application, it is divided into neurology, hematology, immunology, critical care, and others. On the basis of end user, it is bifurcated into hospitals and clinical research laboratories. By country, it is analyzed across Russia, Kazakhstan, Indonesia, China (Including Taiwan), India, Saudi Arabia, Egypt, Vietnam, Argentina, Thailand, and Nigeria.

In terms of value, by product, immunoglobulin is the largest segment in the plasma fractionation market and is also expected to exhibit the fastest growth rate during the forecast period. The growth of this segment is attributable to the diversified use of immunoglobulin in various disorders such as primary and secondary immune deficiencies, autoimmune diseases, and inflammatory diseases. Furthermore, surge in research related to immunology across the globe is another factor that contributes toward the growth of the immunoglobulin market.

In terms of value, by application, neurology acquired the largest share of plasma fractionation market and is also the fastest growing segment during the forecast period. This is attributable to the surge in the neurological disorders that require plasma fractionation products for treatment. Furthermore, surge in the adoption of plasma fractionation products in the field of neurology is another major factor that contributes toward the growth of the market.

In terms of value, on the basis of end user, hospitals acquired the major share of the market and is also expected to register fastest growth rate during the forecast period owing to the rise in number of hospitals worldwide. Furthermore, plasma derivatives are employed in medical filed such as critical care, hematology, and others. The treatment for these medical conditions is performed in the specialized medical facilities by skilled professional present in hospitals. Therefore, factors aforementioned contribute to the growth of the market.

On the basis of country, China (including Taiwan) is expected to grow at the fastest growth rate during the forecast period. The growth is attributable to presence of large population which has a huge demand for plasma fractionation products. Furthermore, surge in various medical conditions that require the use of plasma fractionation products is another major factor that contributes to the growth of market.

Key Findings of the Plasma fractionation Market:
In terms of value, immunoglobulins segment occupied two-third share of the global plasma fractionation market in 2018.
By application, Neurology segment is anticipated to grow with the highest CAGR throughout the forecast period.
By application, others segment accounted for two-third share of the market in terms of value in 2018.
China (including Taiwan) is anticipated to grow at the highest rate during the Plasma Fractionation Market analysis period.

Companies Mentioned

• Grifols SA
• Baxter International Inc.
• CSL LTD.
• Bio Product Laboratory
• Octapharma AG
• Sanquin
• Laboratoire Franais Du Fractionnement Et Des
• Kedrion
• Biotest
• Takeda Pharmaceuticals.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.